Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple back move ease shoulder pain? new trial tests the idea

NCT ID NCT07525297

Symptom relief Sponsor: Yuzuncu Yil University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a gentle back-mobilization technique to standard shoulder therapy can improve pain, movement, and function in people with rotator cuff injuries. Forty adults with chronic shoulder pain will receive either shoulder mobilization alone or combined with thoracic spine mobilization over three weeks. The goal is to see if treating the whole shoulder-upper back chain works better than focusing only on the shoulder.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Manual therapy techniques (Mulligan mobilization with movement and thoracic spine mobilization)
What this could lead to
If this works, it could show that adding a simple back-mobilization technique to standard shoulder therapy provides better pain relief and movement for people with rotator cuff problems.
What could go wrong
This is a very small, early-stage trial with only 40 participants and a short 3-week follow-up. Results may not apply to everyone, and the benefit over standard care alone may be small or nonexistent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Having been diagnosed with unilateral rotator cuff pathology (impingement syndrome, tendinopathy, or partial tear) by a specialist physician through clinical examination and/or radiological imaging (USG/MR); * Being between 18 and 65 years of age; * Having shoulder pain that has persisted for at least 3 months; * Having a positive result on at least two of the Neer, Hawkins-Kennedy, and Empty Can tests; * Having a pain intensity of at least 3/10 on the Pain Numerical Rating Scale (NPRS) during rest or activity; * Having sufficient cognitive ability to follow simple instructions and administer the tests; * Having a Mini Mental State Test score ≥24; * Having the ability to provide signed informed consent and agreeing to participate in the study voluntarily. Exclusion Criteria: * Having undergone previous surgery on the shoulder or thoracic region; * Having full-thickness rotator cuff tears requiring surgical indication; * Having adhesive capsulitis, shoulder instability, labrum tears, or calcific tendinitis; * Having cervical radiculopathy or neurological diseases affecting the upper extremity; * Having uncontrolled diabetes, inflammatory rheumatic diseases (rheumatoid arthritis, etc.), or malignancy; * Having severe osteoporosis, unstable vertebral fractures, or active infection in the thoracic region; having received steroid (cortisone) or PRP injections to the shoulder region within the last 3 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rotator cuff injuries are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity Rotator Cuff Injuries rotator cuff syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Rotator cuff injuries

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Van Yüzüncü Yıl University

    Van, Tuşba, 65080, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.